Reperfusion Therapy with Rapamycin Attenuates Myocardial Infarction through Activation of AKT and ERK

Prompt coronary reperfusion is the gold standard for minimizing injury following acute myocardial infarction. Rapamycin, mammalian target of Rapamycin (mTOR) inhibitor, exerts preconditioning-like cardioprotective effects against ischemia/reperfusion (I/R) injury. We hypothesized that Rapamycin, giv...

Descripción completa

Detalles Bibliográficos
Autores principales: Filippone, Scott M., Samidurai, Arun, Roh, Sean K., Cain, Chad K., He, Jun, Salloum, Fadi N., Kukreja, Rakesh C., Das, Anindita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5360974/
https://www.ncbi.nlm.nih.gov/pubmed/28373901
http://dx.doi.org/10.1155/2017/4619720

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5360974/
https://www.ncbi.nlm.nih.gov/pubmed/28373901
http://dx.doi.org/10.1155/2017/4619720

Ejemplares similares